Perrigo Company plc announced the appointment of Uwe Röhrhoff as president Chief Executive Officer, effective January 15, 2018, following the retirement of John T. Hendrickson. Mr. Röhrhoff has more than 25 years of experience with Gerresheimer AG. Mr. Röhrhoff serves as Audit Committee Chairman on the Board of Directors of Catalent Inc. Mr. Hendrickson will resign as CEO and board member on January 15, 2018 and will remain with the Company until March 15, 2018 to ensure a smooth and successful transition.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.72 USD | +2.33% | +2.06% | -13.86% |
Jul. 11 | Piper Sandler Trims Price Target on Perrigo to $35 From $36, Maintains Overweight Rating | MT |
Jul. 10 | Perrigo Divests HRA Pharma Rare Diseases Business to Esteve Healthcare | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.86% | 3.78B | |
+55.35% | 815B | |
+32.24% | 597B | |
-0.10% | 377B | |
+15.47% | 319B | |
+13.10% | 310B | |
+16.13% | 247B | |
+14.29% | 228B | |
+16.54% | 180B | |
+4.31% | 170B |
- Stock Market
- Equities
- PRGO Stock
- News Perrigo Company plc
- Perrigo Company plc Announces Executive Changes